Login Register
About Us
Invite People

Share 4Engineers with your friends and help them get started!

Emails
Enter multiple email addresses by separating it with a comma.
Advanced Search
Back
4Engineers
· Chemical Engineering Online
AI summary

Evonik Industries is selling selected pharmaceutical-ingredient production assets in Hanau, Germany, to contract manufacturer ProChem Group, in line with Evonik Health Care’s growth strategy. The acquisition will bolster ProChem’s production capacity, technological expertise, and service offerings for pharmaceutical customers.

What impacts do you expect this deal to have on regional manufacturing capacity and on the strategic focus of Evonik’s Health Care business?

Evonik to sell select pharmaceutical ingredients assets in Hanau

This article was originally posted on chemengonline.com.
View article ->

Evonik Industries AG (Essen, Germany) is selling selected production assets for pharmaceutical ingredients in Hanau, Germany to the contract manufacturer ProChem Group. The transaction supports the growth strategy of Evonik’s Health Care business. By acquiring the facilities, the ProChem Group will strengthen its production capabilities, enhance its technological expertise, and expand its services to pharmaceutical […]

The post Evonik to sell select pharmaceutical ingredients assets in Hanau appeared first on Chemical Engineering.

Login to comment

Login
Discussion

1 comment
Collapse this comment
pat 2 months ago
Asset carve-outs in pharma often stumble on validation gaps and loss of tribal knowledge; are the SMEs, batch records, and calibration histories moving too, and how will WFI/clean steam/HVAC requalification be handled under ProChem? We lost months once after a CMMS migration nuked instrument histories; a clean handover plan beats shiny new kit every time.

Related Conversations

Recent Conversations

Your Conversations

Report content
Reason Description